INTCO Medical Wins Three Major Pharmaceutical Industry Awards

From a global glove leader to a benchmark enterprise in the pharmaceutical industry, INTCO Medical continues to gain recognition for its steady growth and ongoing industrial transformation.

On November 10, at the 2024–2025 Annual Industry Conference hosted by the China Chamber of Commerce for the Pharmaceutical Industry (CCPIE) under the All-China Federation of Industry and Commerce, Mr. Liu Fangyi, Chairman of INTCO Medical, was honored with the “Outstanding Contributor of the Year in the Pharmaceutical Industry” award for his exceptional leadership and industry influence.

At the same event, INTCO Medical also secured two additional prestigious recognitions — it was listed among the “Top 100 Pharmaceutical Industrial Enterprises by Operating Revenue” and ranked among the “Top 50 Fastest-Growing Pharmaceutical Enterprises.” These achievements further solidify INTCO Medical’s position as a leading and influential force within the healthcare and medical manufacturing sectors.

As one of China’s most authoritative and influential organizations in the pharmaceutical field, the CCPIE’s annual selection evaluates companies across multiple dimensions, including revenue scale, growth rate, innovation capacity, and contribution to the industry. The awards aim to commend entrepreneurs and enterprises that have made remarkable contributions to the development of China’s pharmaceutical industry.

Under the leadership of Chairman Liu Fangyi, INTCO Medical has maintained its core focus on disposable gloves, while steadily expanding into medical consumables, rehabilitation equipment, and physical therapy products. The company continues to enhance its production capacity, intelligent manufacturing capabilities, and global business layout, establishing itself as a benchmark enterprise in the medical device sector.

In recent years, INTCO Medical’s performance has set a strong example for the industry. In 2024, the company achieved CNY 9.523 billion in operating revenue, marking a 37.65% year-on-year increase. For the first three quarters of 2025, INTCO recorded CNY 7.425 billion in operating revenue, up 4.60% year-on-year, demonstrating remarkable resilience amid complex global market conditions.

Today, INTCO Medical stands as a global leader in disposable glove manufacturing, with products exported to over 150 countries and regions across the Americas, Europe, Asia, Africa, and Oceania, serving more than 15,000 customers worldwide with practical, high-quality medical and healthcare solutions.

Winning these three industry awards is not only a recognition of Chairman Liu Fangyi’s long-term dedication and achievements in the healthcare field but also a testament to INTCO Medical’s contribution to the high-quality development of the pharmaceutical industry.

Looking ahead, INTCO Medical will continue to pursue sustainable, high-quality growth, enhance automation, digitalization, and intelligent manufacturing, and strengthen its R&D and innovation capabilities. At the same time, the company will continue to fulfill its corporate social responsibilities, advance global healthcare progress, and contribute to the continued transformation and modernization of China’s pharmaceutical industry.